search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
70 MARINE INGREDIENTS The marine ingredient at 3% decreased


wrinkle length by 40.6%±13.2% (Figure 5), data supported by the outstanding increase in elasticity of 39.9% in crow’s feet area (Figure 6A) and 29.1% in eye bags after 28 days (Figure 6B).


The marine ingredient increased moisture


from day 0 to day 28, 10.7% in crow’s feet area (Figure 7A) and 16.5% in eye bags area (Figure 7B). The above results highlight that the marine ingredient is a potent well-ageing. Additionally, the marine ingredient was


shown to reduce dark circles by 25.6%±11.7%. Moreover, it helped to reduce the angle formed by eye bags by 10.6%±4.6% (Figure 8), and lifted eyelids in a 10.9%±5.4%.


Tips for formulators The marine ingredient is composed of a blend of polyphenols, proteins and saccharides extracted from nannoplankton as an upcycled ingredient from a green and environmentally friendly downstream process. This 360º eye contour ingredient is water-soluble, 100% natural origin content (ISO 16128), and Vegan and COSMOS-approved. The marine ingredient is easy to formulate


together with other natural ingredients to produce an eye contour end product that covers marketing claims such as: well-ageing to reduce crow’s feet, eye bag wrinkles, eye bag area and improved antioxidant action. It also offers benefits such as eyelid


tensor effect; firming and lifting thanks to the moisturizing effect and elasticity increase; and whitening, reducing dark circles. An example of eye contour formulation is shown in Table 2.


Conclusions OpenSee Phycoskin® is composed of four key molecules: the polyphenols 4-hydroxybenzaldehyde and marine gallic acid, and the proteins thioredoxin and FSA-1 domain protein, which together have been shown to cover multiple claims related to eye contour: ■ Exhibited high antioxidant capacity ■ Increased collagen type I and elastin at only 0.3% dosage ■ Increased elasticity and moisture ■ Reduced wrinkle length by 40.6%±13.2% ■ Reduced dark circles by 25.6%±11.7% ■ Reduced eye bag`s area by 10.6%±6% ■ Exhibited eyelid tensor effect by 10.9%±5.9%


PC


References to this article are available at: https://bit.ly/49n77K7


Day 0


Figure 7: Moisture value (%) increase. In vivo study. Doble-blind test with 36 volunteers (31-63 years old). Marine ingredient applied twice a day at 3% for 28 days. A: Crow’s feet area; B: Eye bags area. P>0.05; one-way ANOVA


Day 28 B


80 70 60 50 40 30 20 10 0


+29.1%* -8.9%* A


100 90 80 70 60 50 40 30 20 10 0


+39.9%* -17.2%*


Marine Ingredient 3%


Placebo


Marine Ingredient 3%


Placebo


Figure 6: Elasticity value (%) increase. In vivo study. Doble-blind test with 36 volunteers (31-63 years old). Marine ingredient applied twice a day at 3% for 28 days. A: crow’s feet area; B: Eye bags area. P>0.05; one-way ANOVA


A


80 70 60 50 40 30 20 10 0


B


80 70 60 50 40 30 20 10 0


+16.5%* -5.5%* +10.7%* -2.3%*


Marine Ingredient 3%


Placebo


Marine Ingredient 3%


Placebo


Figure 8: In vivo study of the marine ingredient at 3%. Visual effect on dark circles and eye bags reduction after 28 days. Images processed with Image J software PERSONAL CARE March 2024 www.personalcaremagazine.com


Moisture value (%)


Moisture value (%)


Elasticity value (%)


Elasticity value (%)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112